Abstract
Purpose
To elucidate detailed epidemiological profile of common types of anterior uveitis (AU) in real-world clinical setting of a tertiary facility in Japan, and to evaluate the characteristic clinical findings at initial presentation.
Study design
Retrospective cohort study.
Methods
Clinical charts of 275 patients (335 eyes) aged 52.5 ± 19.1 years were reviewed retrospectively. Herpetic AU was diagnosed by multiplex polymerase chain reaction tests using aqueous humor. Time of uveitis onset, gender, laterality, disease course since the initial onset of AU, visual acuity (VA) and intraocular pressure (IOP) at first visit, and definitive diagnosis were collected from clinical charts.
Results
Acute AU (AAU) was the most common (21.8%) form of AU; followed by herpetic AU (20.7%) comprising Herpes Simplex Virus (HSV) (8.0%), Varicella Zoster Virus (VZV) (9.1%) and cytomegalo virus (CMV) (3.6%); scleritis (13.5%); diabetic iritis (7.6%), and Posner-Schlossman syndrome (5.5%). Unilateral AU constituted 78.2%, and VA less than 20/30 accounted for 31.2%. Of all the eyes, 16.1% had an IOP higher than 20 mmHg, out of which 37.0% had herpetic AU, followed by scleritis in 25.9%, and Posner-Schlossman syndrome (PSS) in 11.1%. AU patients over 60 years of age were 40.4%, in which 34.2% had herpetic AU, followed by scleritis in 14.4% and AAU in 13.5%. Herpetic AU patients were significantly older and had higher IOP compared with AAU patients.
Conclusion
The most frequent AU was AAU, followed by herpetic AU. Herpetic AU patients were older and had higher intraocular pressure than AAU patients, although VA was equally impaired in both groups.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Uveitis is a sight-threatening inflammatory ocular disease with an annual incidence of 17–52 per 100,000 and a prevalence of 38–370 per 100,000 population [1, 2]. Up to 10% of patients with uveitis experience severe permanent visual impairment mainly as a result of direct ischemic and inflammatory damage of ocular tissues or serious ocular complications [3]. Depending on the primary anatomical location of ocular inflammation, uveitis can be classified into anterior uveitis (AU), intermediate uveitis, posterior uveitis, and panuveitis [4]. The term AU is used for the subset of uveitis with the major inflammation site in the iris (iritis), the anterior part of the ciliary body (anterior cyclitis) or both structures (iridocyclitis). AU is the most common form of uveitis and the incidence in the general population varies among countries [5,6,7,8,9,10,11]. Some AU entities are caused by infectious agents and others appear to be associated with abnormal immune reactions with only ocular involvement or with systemic diseases, but may also present as masquerade syndrome. AU is also classified by clinical course into acute AU (AAU) with sudden onset and limited duration, recurrent AU with repeated episodes separated by periods of inactivity without treatment for ≥ 3 months, and chronic AU that persists and relapses in less than 3 months after discontinuing treatment [4]. AU is a benign disease, and serious complications can be avoided if the causative disease is diagnosed accurately and treated early. To this end, it is critical to know the background characteristics of the patient’s causative disease whenever known, or to estimate the clinical course based on ocular findings even if the causative disease cannot be identified.
Noninfectious AU is represented by AAU (including HLA-B27–negative AAU) with or without ankylosing spondylitis [12,13,14], while the most common infectious AU is herpetic AU mainly caused by reactivation of herpes simplex virus (HSV), varicella-zoster virus (VZV) or cytomegalovirus (CMV) [15,16,17]. In children, juvenile idiopathic arthritis (JIA) and tubulointerstitial nephritis uveitis syndrome (TINU) are frequent causative diseases of AU [18,19,20]. In real-world clinical setting, however, typical ocular findings of different AU entities may not always be observable because of variations in patient background including age, duration from onset to consultation, severity, other concomitant ocular diseases, and disease modification by initial treatment. Therefore, understanding the general demographic and clinical characteristics such as age distribution, gender ratio, laterality, visual acuity (VA), and intraocular pressure (IOP) at initial onset of different entities of AU may provide diagnostic clues. To the best of our knowledge, no study has comprehensively investigated the frequencies of clinical findings at presentation and patient background related to the causative diseases of common forms of AU encountered in clinical practice. The purpose of this study was to elucidate detailed epidemiological profiles of common types of AU in real-world clinical setting of a tertiary facility in Japan, and to evaluate the characteristic clinical findings at initial presentation.
Methods
Clinical charts of consecutive patients diagnosed with AU for the first time at National Defense Medical College Hospital between April 2010 and March 2020 were reviewed retrospectively. The present study was approved by the ethics committee of National Defense Medical College Hospital IRB (2201-34). Anatomical types of uveitis were classified according to the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria [4]. Behçet disease (BD) was diagnosed by the criteria established in Japan [21,22,23]. AAU (including HLA-B27– negative cases) was diagnosed on the basis of typical symptoms including blurred vision, ocular redness, pain and photophobia, ocular findings of non-granulomatous anterior inflammation characterized by fine keratic pretipitates, numerous anterior chamber cells occasionally with hypopyon and lack of iris nodules, and no systemic complications except for ankylosing spondylitis or psoriasis [13, 24,25,26]. AU with mild anterior ocular inflammation indistinguishable between granulomatous and non-granulomatous uveitis was classified as idiopathic AU, even when accompanied by typical AAU symptoms. The multiplex PCR qualitatively measured the genomic DNA of 8 HHVs: herpes simplex virus (HSV) type 1 (HHV-1), HSV-2 (HHV-2), varicella-zoster virus (VZV; HHV-3), Epstein-Barr virus (EBV; HHV-4), CMV (HHV-5), HHV-6, HHV-7, and HHV-8 using the aqueous humor [27, 28]; whenever herpetic AU was suspected judging from clinical features including unilateral involvement, presence of granulomatous keratic precipitates, and/or elevated IOP [29], a definitive diagnosis was made according to the SUN Working Group criteria [30,31,32]. Patients with suspected herpetic AU who had negative PCR results were not classified as herpetic AU; the cases with clinical features similar to CMV-associated AU were diagnosed as Posner-Schlossman syndrome (PSS) whereas any others were classified as idiopathic AU. Since, to date there are no diagnostic criteria for diabetic iritis, non-granulomatous AU occurring in patients who had uncontrolled diabetes with highly elevated HbA1c (> 10.0%) was diagnosed as diabetic iritis [33]. Diagnosis of TINU and Fuchs uveitis syndrome (FUS) was made according to the SUN Working Group criteria [34, 35]. Other uveitis diseases such as JIA-associated uveitis and lens-induced uveitis were diagnosed according to a previous report [38].
Time of uveitis onset, gender, laterality, disease course since the initial onset of AU, VA, IOP at first visit, and definitive diagnosis were collected from clinical charts. Statistical analysis was performed using JMP Pro ver. 15 (Business Unit of SAS). Continuous variables were compared by Mann–Whitney U test, and categorical variables were analyzed using Pearson χ2 test or Fisher’s exact test. P values lower than 0.05 were considered statistically significant.
Results
Background and ophthalmological data of all AU patients
A total of 335 eyes of 275 consecutive patients were enrolled in this retrospective cohort study. Background and ophthalmological data of AU patients at presentation are shown in Table 1. Mean patient age was 52.5 ± 19.1 years (median 53 years), and 45.1% were men. Unilateral uveitis was predominant (215 patients, 78.2%). Mean logMAR of AU eyes was 0.27 ± 0.78 (median 0), and 107 eyes (32.0%) had a BCVA of less than 20/30. Mean IOP of AU eyes was 16.1 ± 7.6 mmHg (median 14 mmHg). Fifty-four eyes (16.1) had IOP higher than 20 mmHg, and mean IOP of this subset was 29.5 ± 9.3 mmHg (median 25.8 mmHg, range 21–59 mmHg). Figure 1 shows the age distribution of male and female AU patients, and mean logMAR and IOP in AU eyes. AU was predominant in age groups of 40–70 s, and female predominance was observed in juvenile patients (aged up to 20) and older patients (aged 70 and above). LogMAR tended to increase with age.
AU types diagnosed and the frequencies
Table 2 shows AU types diagnosed and their frequencies. The most frequent form of AU was AAU, found in 60 patients (21.8%), followed by herpetic AU in 57 patients (20.7%) [comprising herpes simplex virus (HSV) in 22 patients (8.0%), varicella zoster virus (VZV) in 25 patients (9.1%), and cytomegalovirus (CMV) in 10 patients (3.6%)], scleritis in 37 patients (13.5%), diabetic iritis in 21 patients (7.6%), and PSS in 15 patients (5.5%). Idiopathic AU was diagnosed in 47 patients, constituting 17.1% of the total. Lens-induced uveitis had the highest mean age of 85.0 ± 12.1 years, followed by CMV-related AU of 65.4 ± 9.9 years.
Unilateral AU types and the frequencies
Unilateral uveitis was found in 215 patients, accounting for 78.2% of total AU cases. Table 3 shows the frequencies of AU types in unilateral AU cases, and the percentage of unilateral disease in AU cases for each AU type. The most frequent unilateral AU was herpetic AU found in 55 patients (25.6%) [comprising HSV in 22 patients (10.2%), VZV in 25 patients (11.6%), and CMV in 8 patients (3.7%)], followed by AAU in 52 patients (24.2%), scleritis in 28 patients (13.0%), PSS in 15 patients (7.0%), and diabetic iritis in 12 patients (5.6%). The percentage of unilateral disease in AU patients was 100% for VZV- and HSV-associated AU, PSS, and lens-induced uveitis; 88.9% for FUS; 86.7% for AAU; 80% for CMV-associated AU; and 77.8% for AU with inflammatory bowel disease.
AU types with disturbed visual acuity
The number of AU eyes with VA less than 20/30 was 107, accounting for 31.9% of all AU eyes. Table 4 shows the frequencies of AU types in AU eyes with disturbed VA, and the percentage of disturbed VA in AU eyes for each AU type. The most frequent AU with disturbed VA was herpetic AU found in 29 eyes (29.3%), in which HSV in 12 eyes (12.1%), VZV in 12 eyes (12.1%), and CMV in 5 eyes (5.1%), followed by AAU in 29 eyes (28.3%), diabetic iritis in 13 eyes (10.1%), scleritis in 8 eyes (6.1%), and FUS in 5 eyes (5.1%). The percentage of disturbed VA in AU eyes was 100% for lens-induced uveitis, 61.9% for diabetic iritis, 55.6% for FUS, 54.5% for HSV-associated AU, 50.0% for CMV-associated AU, 48.3% for AAU, and 48.0% for VZV-associated AU.
AU types with high intraocular pressure
The number of AU eyes with IOP higher than 20 mmHg was 54, accounting for 16.1% of all AU eyes. Table 5 shows the frequencies of AU types in AU eyes with high IOP, and the percentage of high IOP in AU eyes for each AU type. The most frequent AU with high IOP was herpetic AU found in 20 eyes (37.0%) [comprising HSV in 7 eyes (13.0%), VZV in 6 eyes (11.1%), and CMV in 6 eyes (11.1%)] followed by scleritis in 14 eyes (25.9%), PSS in 6 eyes (11.1%), AAU in 4 eyes (7.4%), and diabetic iritis in 3 patients (5.6%). The percentage of high IOP in AU eyes was 60% for CMV-associated AU, 40% for PSS, 37.8% for scleritis, 33.3% for lens-induced uveitis, 31.8% for HSV-associated AU, and 24.0% for VZV-associated AU.
AU types in patients over 60 years of age
The number of AU patients over 60 years of age was 111, accounting for 40.4% of total AU patients. Table 6 shows the frequencies of AU types in AU patients aged over 60 years, and the percentage of over age 60 in AU patients for each AU type. The AU with the highest frequency of patients aged over 60 was herpetic AU found in 38 patients (34.2%) [comprising HSV in 14 patients (12.6%), VZV in 16 patients (14.4%), and CMV in 8 patients (7.2%)], followed by scleritis in 16 patients (14.4%), AAU in 15 patients (13.5%), PSS in 7 patients (6.3%), and diabetic iritis in 5 patients (4.5%). The percentage of age over 60 in AU patients was 100% for lens-induced uveitis, 80% for CMV-associated AU, 64.0% for VZV-associated AU, and 63.6% for HSV-associated AU. The percentage of patients aged over 60 in other AU types was less than 50%.
Comparison of acute anterior uveitis with herpetic anterior uveitis
Figure 2 compares the male/female ratio, age, logMAR, and IOP between AAU and herpetic AU. Herpetic AU patients were significantly older than AAU patients and IOP was higher in herpetic AU eyes than in AAU eyes, although there was no significant difference in male/female ratio or logMAR between AAU and herpetic AU.
Comparison of cytomegalovirus-associated anterior uveitis with Posner-Schlossman syndrome
Figure 3 shows the comparisons of male/female ratio, age, logMAR, and IOP between CMV-associated AU and PSS. LogMAR was significantly higher in CMV-associated AU than in PSS. Although the CMV-associated AU group had apparently higher male/female ratio, higher age, and lower IOP than the PSS group, the differences were not statistically significant.
Discussion
In the present study population, AU occurred in all age groups, but was more common in middle-aged and older groups. Unilateral AU occupied 78% of all AU cases and there was no gender predominance. On the other hand, juvenile AU was bilateral and more common in girls. Although there were only 19 (14.5%) AU patients younger than 20 years of age, our results are comparable with a previous report [39].
AU is the most common uveitis in Western and some Asian countries [1, 5,6,7,8,9,10,11], but occupies the second place in Japan [38, 40, 41]. The epidemiology of uveitis varies considerably depending on the geographic location, race, and social and economic environment [42]. Panuveitis, represented by sarcoidosis, Vogt-Koyanagi-Harada disease and BD, is the most common form of uveitis in Japan, although BD has been decreasing in recent years [38, 43, 44]. In addition, although AAU has the highest frequency among all uveitis diseases in Western countries, the proportion of AAU in uveitis in Japan is less than 10% [38, 44]. One of the contributing factors to AAU is considered to be the HLA-B27 allele. Approximately 55% of Caucasian patients with AAU are HLA-B27–positive, and the HLA-B27 allele is found in 8–10% of the general population [45, 46]. However, the frequency of the HLA-B27 allele is only 0.4% in Japanese [47]. This does, at least in part, explain the relatively low frequency of AAU in Japan [38, 44].
In the 2009 epidemiological survey of uveitis in Japan, the frequency of herpetic AU was 4.2% of all uveitis cases, lower than the 6.5% frequency of AAU [44]. In the 2016 survey, however, the proportion of herpetic AU increased to 6.5%, higher than the 5.5% rate of AAU [38]. The frequency of herpetic AU was 6.5% in all uveitis cases and 21.4% in AU cases; the latter is comparable to the frequency of 20.7% in this study. AAU is more common in young and middle-aged adults [48, 49], while herpetic AU occurs more frequently in older patients [37, 50, 51]. In the present study also, the mean age of herpetic AU patients was 60.6 ± 17.1 years, significantly higher than that of AAU (48.4 ± 15.0 years). A notable finding is that more than 40% of all AU patients were over 60 years of age, and one-third of these patients had herpetic AU. A study investigating characteristics of de novo uveitis in patients older than 60 years reports that herpetic AU had the highest frequency among the AU types with specific diagnosis, although idiopathic uveitis accounted for the majority of cases [52]. A review article also shows that herpetic AU was a common cause of AU among elderly patients [53]. Aging of the population is progressing all over the world including Japan, and the increase in herpetic AU may be related to the demographic change underlying the aging society.
Since severe anterior inflammation reduces the function of the ciliary body, IOP is usually lower in AAU patients [54]. Mean IOP of AAU eyes was 13.3 ± 4.2 mmHg, lower than the 16.1 ± 7.6 mmHg in total AU eyes. However, IOP higher than 20 mmHg was observed in 4 AAU eyes (6.67%), 3 of whom had high IOP caused by pupillary block whereas 1 eye had primary open angle glaucoma. On the other hand, high IOP is a characteristic complication of herpetic AU; especially, CMV-associated AU may lead to glaucomatous optic neuropathy [55]. However, the proportions of herpetic AU with high IOP were relatively low in this study; 60% of CMV-associated AU, 31.8% of HSV-associated AU, and 24.0% of VZV-associated AU. Some herpetic AU patients were referred to our facility after the elevated IOP at initial AU onset had been controlled by eyedrops prescribed by other facilities, but some were not. Therefore, even when medical history of high IOP is unknown, PCR using aqueous humor samples is highly recommended for AU patients with unilateral disease, keratic precipitates characteristic of herpetic AU, and elderly onset.
Chee and Jap [56] detected CMV viral DNA in the aqueous humor of eyes with presumed PSS by PCR analysis, leading to the recognition of CMV-associated AU as a new entity separate from PSS. Unilateral hypertensive AU with a few white granulomatous keratic precipitates is the characteristic clinical finding of CMV-associated AU, but is also commonly found in PSS [55, 57]. Loss of corneal endothelial cells during the clinical course is observed in CMV-associated AU [55, 58], but this feature is not present at the initial onset. Chee and Jap [56] report no differences in clinical features between CMV-negative and CMV-positive PSS (CMV-associated AU) eyes. On the other hand, Murata et al. [59] report that CMV-positive PSS patients (CMV-associated AU) were of older age, had higher IOP, and a more disturbed VA than CMV-negative PSS patients. Hence, the diagnosis of CMV-associated AU requires the detection of CMV-DNA by PCR or anti-CMV antibodies in the aqueous humor. In the present study, patients suspected of CMV-associated AU from their clinical findings but who were tested negative for CMV were classified as PSS. However, PSS patients, in whom a CMV-association was reconsidered following the clinical course, were treated as CMV-associated AU. In some of them, PCR using the aqueous humor was repeated. Therefore, in this study there were some CMV-associated AU patients among the PSS patients. That may be the reason that CMV-associated AU differed significantly from PSS only in logMAR VA, although CMV-associated AU patients apparently had higher male/female ratio and were older.
The proportion of CMV-associated AU among herpetic AU was 17.5%, lower compared to previous reports in Japan [37, 50, 51]. Judging from clinical findings at presentation alone CMV-associated AU is undistinguishable from PSS as described above, although the characteristic clinical course of chronic anterior ocular inflammation, repeated IOP elevation, and decrease in corneal endothelial cells strongly suggests CMV infection. In this study, PCR tests were basically performed only once for each patient. CMV DNA is not always detected by PCR using aqueous humor [60, 61], and test results may be affected by severity of AU and the clinical course. As mentioned above, in this study CMV-associated AU patients tested negative for CMV at the initial presentation was primarily diagnosed as PSS. If PSS patients diagnosed as CMV-associated AU later on in the clinical course were included in CMV-associated AU, the proportion of CMV-associated AU would increase.
The frequency of FUS in this study was higher than in a recent national survey of uveitis in Japan [38]. FUS is non-granulomatous uveitis with latent onset and low-grade activity [62]. It is unlikely that FUS patients visit an ophthalmologist with complaints associated with AU, and the diagnosis is frequently made during routine ophthalmologic examination for blurred vision or floaters related to cataracts or vitreous opacity. Disturbed VA was found in 55.6% of FUS patients, but the cause was cataract and the patients were referred to our facility with unilateral cataracts. In addition, heterochromia is often subtle or even absent in FUS patients with dark irises such as Japanese [63, 64]. Therefore, FUS is potentially an overlooked cause of AU.
There are several limitations to our study. The small number of patients, the retrospective design, single-centre study, the diagnosis of uveitis by ophthalmologists only throughout the study period, and medical information recorded by different observers during follow-up visits may have biased the data. Additionally, because most of patients were referred from other clinics or hospitals, there was a selection bias as some of them had already been treated.
In conclusion, AU occurs in all age groups, but is more common in middle and older age groups. Unilateral AU accounted for approximately 80% of total AU and showed no sex difference in prevalence. AAU was the most common form of AU, followed by herpetic AU and scleritis, and the three together constituted more than 50% of total AU. Visual impairment was observed in one-half of AAU and herpetic AU patients, and high IOP occurred mainly in herpetic AU, PSS and scleritis. Patients with AAU were significantly younger and had lower IOP than those with herpetic AU. On the other hand, more than 40% of all AU patients were over 60 years of age, and herpetic AU was the causative disease in one-third of the AU patients.
References
Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin 2005;45:1–3.
Gonzalez MM, Solano MM, Porco TC, Oldenburg CE, Acharya NR, Lin SC, et al. Epidemiology of uveitis in a US population-based study. J Ophthalmic Inflamm Infect. 2018;8:6.
Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844–8.
Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of uveitis nomenclature working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16.
Oruc S, Kaplan AD, Galen M, Kaplan HJ. Uveitis referral pattern in a Midwest University Eye Center. Ocul Immunol Inflamm. 2003;11:287–98.
Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943–8.
Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297–310.
Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–5.
Hamade IH, Elkum N, Tabbara KF. Causes of uveitis at a referral center in Saudi Arabia. Ocul Immunol Inflamm. 2009;17:11–6.
Bro T, Tallstedt L. Epidemiology of uveitis in a region of southern Sweden. Acta Ophthalmol. 2020;98:32–5.
Hermann L, Falcão-Reis F, Figueira L. Epidemiology of Uveitis in a tertiary care centre in Portugal. Semin Ophthalmol. 2021;36:51–7.
Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am. 1992;18:143–51.
D’Ambrosio EM, La Cava M, Tortorella P, Gharbiya M, Campanella M, Iannetti L. Clinical features and complications of the HLA-B27-associated acute anterior uveitis: a metanalysis. Semin Ophthalmol. 2017;32:689–701.
Yang P, Wan W, Du L, Zhou Q, Qi J, Liang L, et al. Clinical features of HLA-B27-positive acute anterior uveitis with or without ankylosing spondylitis in a Chinese cohort. Br J Ophthalmol. 2018;102:215–9.
Miserocchi E, Waheed NK, Dios E, Christen W, Merayo J, Roque M, et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology. 2002;109:1532–7.
Kawaguchi T, Kawazoe Y, Kamoi K, Miyanaga M, Takase H, Sugita S, et al. Clinical course of patients with Behcet’s uveitis following discontinuation of infliximab therapy. Jpn J Ophthalmol. 2014;58:75–80.
Testi I, Aggarwal K, Jaiswal N, Dahiya N, Thng ZX, Agarwal A, et al. Antiviral Therapy for Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV)-induced anterior uveitis: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:686427.
Goda C, Kotake S, Ichiishi A, Namba K, Kitaichi N, Ohno S. Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol. 2005;140:637–41.
Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology. 2007;114:995–9.
Wells JM, Smith JR. Uveitis in juvenile idiopathic arthritis: recent therapeutic advances. Ophthalmic Res. 2015;54:124–7.
Mizushima Y. [Revised diagnostic criteria for Behcet’s disease in 1987]. Ryumachi. 1988;28:66–70 (in Japanese).
Ishihara M. Validity, usefulness and difficulties of the diagnosis of sarcoidosis by new diagnostic criteria and guidelines for sarcoidosis. Nippon Ganka Gakkai Zasshi. 2010;114:665–7 (in Japanese).
Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet (London). 1990;335:1078–80.
Tuncer S, Adam YS, Urgancioglu M, Tugal-Tutkun I. Clinical features and outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis in a Turkish patient population. Ocul Immunol Inflamm. 2005;13:367–73.
Wakefield D, Zierhut M. Controversy: ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18:5–9.
Wakefield D, Clarke D, McCluskey P. Recent developments in HLA B27 Anterior Uveitis. Front Immunol. 2020;11:608134.
Sugita S, Ogawa M, Shimizu N, Morio T, Ohguro N, Nakai K, et al. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013;120:1761–8.
Mochizuki M, Sugita S, Kamoi K, Takase H. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol. 2017;61:1–20.
Sugita S, Shimizu N, Watanabe K, Mizukami M, Morio T, Sugamoto Y, et al. Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol. 2008;92:928–32.
Classification Criteria for Herpes Simplex Virus Anterior Uveitis. Am J Ophthalmol. 2021;228:231–6.
Classification Criteria for Varicella Zoster Virus Anterior Uveitis. Am J Ophthalmol. 2021;228:165–73.
Classification Criteria for Cytomegalovirus Anterior Uveitis. Am J Ophthalmol. 2021;228:89–95.
Watanabe T, Keino H, Nakayama K, Taki W, Echizen N, Okada AA. Clinical features of patients with diabetic anterior uveitis. Br J Ophthalmol. 2019;103:78–82.
Classification Criteria for Tubulointerstitial Nephritis With Uveitis Syndrome. Am J Ophthalmol. 2021;228:255–61.
Standardization of Uveitis Nomenclature Working G. Classification criteria for Fuchs Uveitis Syndrome. Am J Ophthalmol. 2021;228:262–7.
Deschenes J, Murray PI, Rao NA, Nussenblatt RB. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1–2.
Terada Y, Kaburaki T, Takase H, Goto H, Nakano S, Inoue Y, et al. Distinguishing features of Anterior Uveitis caused by Herpes Simplex Virus, Varicella-Zoster Virus, and Cytomegalovirus. Am J Ophthalmol. 2021;227:191–200.
Sonoda KH, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H, et al. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65:184–90.
Smith JA, Mackensen F, Sen HN, Leigh JF, Watkins AS, Pyatetsky D, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544–51 51 e1.
Kitamei H, Kitaichi N, Namba K, Kotake S, Goda C, Kitamura M, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol. 2009;87:424–8.
Keino H, Nakashima C, Watanabe T, Taki W, Hayakawa R, Sugitani A, et al. Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol. 2009;37:595–601.
Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10:263–79.
Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–4.
Ohguro N, Sonoda KH, Takeuchi M, Matsumura M, Mochizuki M. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432–5.
Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC. Acute anterior uveitis and HL-A 27. Lancet (London). 1973;302:994–6.
Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm. 2011;19:139–44.
Otsuka A, Morita M, Yamada H. Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab. J Orthop Sci. 2015;20:1070–7.
Mapstone R, Woodrow JC. HL-A 27 and acute anterior uveitis. The Br J Ophthalmol. 1975;59:270–5.
Pathanapitoon K, Dodds EM, Cunningham ET Jr, Rothova A. Clinical spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm. 2017;25:569–76.
Sakai JI, Usui Y, Suzuki J, Kezuka T, Goto H. Clinical features of anterior uveitis caused by three different herpes viruses. Int Ophthalmol. 2019;39:2785–95.
Takase H, Kubono R, Terada Y, Imai A, Fukuda S, Tomita M, et al. Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol. 2014;58:473–82.
Chatzistefanou K, Markomichelakis NN, Christen W, Soheilian M, Foster CS. Characteristics of uveitis presenting for the first time in the elderly. Ophthalmology. 1998;105:347–52.
Abdulaal MR, Abiad BH, Hamam RN. Uveitis in the aging eye: incidence, patterns, and differential diagnosis. J Ophthalmol. 2015;2015:509456.
Kanda T, Shibata M, Taguchi M, Ishikawa S, Harimoto K, Takeuchi M. Prevalence and aetiology of ocular hypertension in acute and chronic uveitis. Br J Ophthalmol. 2014;98:932–6.
Chan NS, Chee SP, Caspers L, Bodaghi B. Clinical features of CMV-associated Anterior Uveitis. Ocul Immunol Inflamm. 2018;26:107–15.
Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146:883-9.e1.
Touhami S, Qu L, Angi M, Bojanova M, Touitou V, Lehoang P, et al. Cytomegalovirus Anterior Uveitis: clinical characteristics and long-term outcomes in a French Series. Am J Ophthalmol. 2018;194:134–42.
Miyanaga M, Sugita S, Shimizu N, Morio T, Miyata K, Maruyama K, et al. A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis. Br J Ophthalmol. 2010;94:336–40.
Murata K, Ishida K, Ozawa K, Sawada A, Mochizuki K, Yamamoto T. The characteristics of Posner-Schlossman syndrome: A comparison in the surgical outcome between cytomegalovirus-positive and cytomegalovirus-negative patients. Med (Baltim). 2019;98:e18123.
Choi JA, Kim KS, Jung Y, Park HY, Park CK. Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients. J Ophthalmic Inflamm Infect. 2016;6:32.
De Simone L, Belloni L, Aldigeri R, Zerbini A, Mastrofilippo V, Sangiovanni A, et al. Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience. Graefes Arch Clin Exp Ophthalmol. 2019;257:181–6.
Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234–5.
Tabbut BR, Tessler HH, Williams D. Fuchs’ heterochromic iridocyclitis in blacks. Arch Ophthalmol (Chicago, Ill: 1960). 1988;106:1688–90.
Herbort CP, Khairallah M. Editorial: Fuchs’ uveitis: from Imperial Vienna to global appraisal. Int Ophthalmol. 2010;30:449–52.
Acknowledgements
The study was supported by grants from the Grants-in-Aid for Scientific Research C (M. Takeuchi, 20K09840) from the Japan Society for the Promotion of Science. The authors thank Eiko Machida, Kiyoko Yamada, Tomomi Nakamura, and Saeko Kanno for their contribution to the present report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
R. Okazawa, None; S. Iwai, None; K. Nagura, None; D. Sora, None; T. Sato, None; K. Takayama, None; K. Harimoto, None; T. Kanda, None; M. Takeuchi, None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding Author: Masaru Takeuchi
About this article
Cite this article
Okazawa, R., Iwai, S., Nagura, K. et al. Epidemiology and characteristics of common forms of anterior uveitis at initial presentation in a tertiary facility in Japan. Jpn J Ophthalmol 67, 22–31 (2023). https://doi.org/10.1007/s10384-022-00961-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-022-00961-w